100
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Retrieval of patients with hepatitis C who were lost to follow-up in Southern Denmark

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 361-369 | Received 13 Sep 2022, Accepted 05 Mar 2023, Published online: 17 Mar 2023

References

  • WHO. Global Health Sector Strategy on Viral Hepatitis, 2016-2021: towards ending viral hepatitis. Report No.: WHO reference number: WHO/HIV/2016.06. 2018.
  • Polaris Observatory HCV Collaborators. Global change in hepatitis C virus prevalence and Cascade of care between 2015 and 2020: a modelling study. Lancet Gastroenterol Hepatol. 2022;7(5):396–415.
  • WHO. Interim Guidance for country validation of viral hepatitic elimination. World Health Organization. 2021.
  • CDA Foundation. Countries/Territories achieving relative or absolute impact and programmatic targets – HCV. 2023 https://cdafound.org/polaris-countries-maps/
  • Nielsen S, Hansen JF, Hay G, et al. Hepatitis C prevalence in Denmark in 2016-An updated estimate using multiple national registers. PLoS One. 2020;15(9):e0238203.
  • Medicinrådet. Medicinrådets fælles regionale behandlingsvejledning med lægemiddelrekommandation for kronisk hepatitis C - valg mellem lægemidler. 2018.
  • Dröse S, Øvrehus ALH, Holm DK, et al. A multi-level intervention to eliminate hepatitis C from the region of Southern Denmark: the C-Free-South project. BMC Infect Dis. 2022;22(1):202.
  • Safreed-Harmon K, Blach S, Aleman S, et al. The consensus hepatitis C Cascade of care: standardized reporting to monitor progress toward elimination. Clin Infect Dis. 2019;69(12):2218–2227.
  • Aleman S, Soderholm J, Busch K, et al. Frequent loss to follow-up after diagnosis of hepatitis C virus infection: a barrier towards the elimination of hepatitis C virus. Liver Int. 2020;40(8):1832–1840.
  • Heil J, Soufidi K, Stals F, et al. Retrieval and re-evaluation of previously diagnosed chronic hepatitis C infections lost to medical follow-up in The Netherlands. Eur J Gastroenterol Hepatol. 2020;32(7):851–856.
  • Francesca Romana P, Francesco S, Massimo S, et al. Missed linkage to care for patients who screened positive for hepatitis C in a tertiary care center: results of the telepass project. J Viral Hepat. 2021;28(4):651–656.
  • van Dijk M, Drenth JPH, HepNed study group. Loss to follow-up in the hepatitis C care Cascade: a substantial problem but opportunity for micro-elimination. J Viral Hepat. 2020;27(12):1270–1283.
  • Yen HH, Su PY, Liu II, et al. Retrieval of lost patients in the system for hepatitis C microelimination: a single-center retrospective study. BMC Gastroenterol. 2021;21(1):209.
  • Mössner BH, Øvrehus A, Nymark A, et al. Patienter med viral hepatitis B og C region syd, Midt Og Nord Årsrapport 2016. Report of patients with viral hepatitis in the west of Denmark 2016 from the clinical database infcare hepatitis. (in danish). 2017.
  • Afdhal NH, Bacon BR, Patel K, et al. Accuracy of fibroscan, compared with histology, in analysis of liver fibrosis in patients with hepatitis B or C: a United States multicenter study. Clin Gastroenterol Hepatol. 2015;13(4):772–779. e1–3.
  • Kracht PAM, Arends JE, van Erpecum KJ, et al. REtrieval and cure of chronic hepatitis C (REACH): results of micro-elimination in the Utrecht province. Liver Int. 2019;39(3):455–462.
  • Isfordink CJ, Brakenhoff SM, van Dijk M, HepNed study group, et al. Hepatitis C elimination in The Netherlands (CELINE): study protocol for nationwide retrieval of lost to follow-up patients with chronic hepatitis C. BMJ Open Gastroenterol. 2020;7(1):e000396.
  • Isfordink CJ, van Dijk M, Brakenhoff SM, et al. Hepatitis C elimination in The Netherlands (CELINE): how nationwide retrieval of lost to follow-up hepatitis C patients contributes to micro-elimination. Eur J Intern Med. 2022;101:93–97.
  • Simpson H, Manley P, Lawler J, et al. Distance to treatment as a factor for loss to follow up of hepatitis C patients in North East England. J Public Health. 2019;41(4):700–706.
  • Del Pino Bellido P, Guerra Veloz MF, Cordero Ruíz P, et al. Chronic hepatitis C patients lost IN THE system: predictive factors OF non-referral OR loss OF follow UP TO hepatology units. Rev Esp Enferm Dig. 2021;113(12):833–839.
  • Dröse SC, Holm DK, Røge BT, et al. Baseline capability for hepatitis test and treatment in drug treatment clinics in the region of Southern Denmark- a pre-elimination intervention assessment. Sydney: INHSU; 2021.
  • Cunningham EB, Wheeler A, Hajarizadeh B, et al. Interventions to enhance testing, linkage to care, and treatment initiation for hepatitis C virus infection: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2022;7(5):426–445.
  • Medicinrådet. Medicinrådets lægemiddelrekommandation og behandlingsvejledning vedrørende lægemidler til hepatitis C. 2022.
  • Silano JA, Treloar C, Leadbeatter K, et al. Peer-facilitated treatment access for hepatitis C: the live hep C free project. Harm Reduct J. 2022;19(1):40.
  • Droese S, Madsen LW, Harvald GB, et al. Screening for hepatitis C in Denmark-the effect of a mobile outreach intervention. J Hepatol. 2022;77: s550.
  • Mason K, Dodd Z, Guyton M, et al. Understanding real-world adherence in the directly acting antiviral era: a prospective evaluation of adherence among people with a history of drug use at a community-based program in toronto, Canada. Int J Drug Policy. 2017;47:202–208.
  • Blach S, Kondili LA, Aghemo A, et al. Impact of COVID-19 on global hepatitis C elimination efforts. Journal of Hepatology. 2020;74(1):31–36.
  • Wentworth JJ, Øvrehus ALH, Hansen JF, et al. Emergency department testing is feasible but ineffective to eliminate hepatitis C in Denmark. Infect Dis. 2021;53(12):930–941.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.